A service of StreetInsider.com
Ticker Symbol
Welcome

Most Popular

AAPL 496.07
C 32.95
GOOG 606.81
BAC 8.09
RIMM 15.57

Recently Added

CPIC 1.17
SHMX 0.00
NBTH 12.50
COHO 0.00
PZZI 4.77

Gaining Speed

COHO 0.00
SHMX 0.00
CPIC 1.17
NBTH 12.50
IDVC 0.35
1.43 -0.06 (-4.05%) DYAX

Click Here to Receive Instant E-mail and RSS Alerts


Trade DYAX now with

Stock Details

Last Trade:1.43 Change:-0.06 (-4.05%) Prev Close:1.49 Open: 1.48 Days Range:1.38 – 1.49 52 Week Range: 1.10 - 2.33 Volume:52304 P/E: N/A
EPS:-0.30





Recent Blog Posts

Blog Posts on 09/08/11 at 3:32pm
Key Companies And Products In The Market To Treat The Orphan Disease Hereditary Angioedema
Blog Posts on 08/30/11 at 12:42am
10 Biotech Stocks Being Dumped By Big Money Managers
Blog Posts on 06/05/11 at 3:01am
Accipiter Capital's Most Favorite Stock Picks
Blog Posts on 03/18/11 at 6:35pm
Low-Priced Biotech Stocks With Insider Buying
Blog Posts on 10/28/10 at 3:46am
Dyax Corporation CEO Discusses Q3 2010 Results - Earnings Call Transcript
Blog Posts on 05/01/10 at 9:59am
Dyax Corporation Q1 2010 Earnings Call Transcript
Blog Posts on 04/04/10 at 4:20am
Biotech Deal Activity Takes a Breather
Blog Posts on 04/04/10 at 3:49am
Antisoma Tumbles After Halting Cancer Trial: Biotech's Latest Mishaps
Blog Posts on 02/17/10 at 2:41pm
Dyax Q4 2009 Earnings Call Transcript
Blog Posts on 12/03/09 at 12:11pm
Dyax: FDA Approval Boosts Prospects
Blog Posts on 10/29/09 at 11:02am
BioMed News Bytes: Dyax, Human Genome Sciences, Aldagen
Blog Posts on 10/28/09 at 3:40pm
Dyax Corp. Q3 2009 Earnings Call Transcript
Blog Posts on 10/17/09 at 10:55am
Comfort Zone Investing: Five stocks for income and growth
Blog Posts on 10/14/09 at 4:16am
FDA Calendar Extreme Trades: 85 Single Digit Stocks
Blog Posts on 09/20/09 at 4:50pm
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Blog Posts on 09/11/09 at 5:49am
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
Blog Posts on 07/27/09 at 4:14am
FDA Calendar: 2H09 Binary Event Trades
Blog Posts on 07/22/09 at 1:29pm
Dyax Corp. Q2 2009 Earnings Call Transcript
Blog Posts on 07/21/09 at 4:13am
Extreme FDA Trades: 20 Stocks Under Bucks
Blog Posts on 06/26/09 at 8:40am
Pharma M&A: Big Bonds and Small Deals
Blog Posts on 06/22/09 at 5:08am
Pending FDA Decisions: 20 Extreme Trades
Blog Posts on 06/18/09 at 4:40am
Seven Laggard Biotech Trades
Blog Posts on 06/09/09 at 5:15am
FDA Calendar Updates: Keryx Biopharma Announces Phase 2 Results
Blog Posts on 06/09/09 at 3:47am
Bio Medical Stock Sector is Where the Action Is
Blog Posts on 05/04/09 at 9:01am
20 Stocks Which May Be Threatening Your Portfolio
Blog Posts on 05/04/09 at 8:53am
20 Stocks to Avoid from Russell 2000
Blog Posts on 04/22/09 at 2:15pm
Dyax Q1 2009 Earnings Call Transcript
Blog Posts on 03/29/09 at 4:31am
FDA and Clinical Trial Updates: Osiris Sees Flaw in Crohn's Disease Trial
Blog Posts on 03/12/09 at 3:07am
Trading FDA Decisions: 14 Candidates
Blog Posts on 10/03/07 at 11:20am
Analyst initiations: AMD, INTC, NTCT, GUID and NDAQ